Psyence Biomedical Ltd. Common Shares (PBM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Psyence Biomedical Ltd. Common Shares (PBM) is Moderate Underperform.

The composite score behind that read is -0.48, weighing +0.00 of bullish evidence against -0.47 bearish.

Psyence Biomedical Ltd. Common Shares last closed at $5.08, -1.55% on the session.

Against the IVW growth benchmark the position is -2.47% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

16 graded predictions for PBM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Psyence Biomedical Ltd. Common Shares is classified under Health Care / Biotechnology, with a market capitalisation of $19.68M.

StockMap tracks Psyence Biomedical Ltd. Common Shares as the 303rd largest of the 344 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 180 Moderate Underperform, 152 Neutral, 11 Strong Underperform and 1 Moderate Outperform.

On that composite Psyence Biomedical Ltd. Common Shares ranks 328th of 344 in the group, against a group median of -0.21.